story of the week
Comparative Effectiveness and Safety Among Apixaban, Dabigatran, Edoxaban, and Rivaroxaban for Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study
Ann. Intern. Med 2022 Nov 01;[EPub Ahead of Print], WCY Lau, CO Torre, KKC Man, HM Stewart, S Seager, M Van Zandt, C Reich, J Li, J Brewster, GYH Lip, AD Hingorani, L Wei, ICK WongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.